ACCUTIP
LIVE

Serial Number

99313787

Owner

LTS Lohmann Therapie-Systeme AG

Attorney

Kirk M. Miles

Filing Date

Jul 31, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ACCUTIP Trademark

Serial Number: 99313787

ACCUTIP is a trademark filed by LTS Lohmann Therapie-Systeme AG on July 31, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

LTS Lohmann Therapie-Systeme AG (10 trademarks)

Lohmannstrasse 2
Andernach 56626 , DE

Entity Type: 99

Trademark Details

Filing Date

July 31, 2025

Registration Date

Not Registered

Goods & Services

Apparatus and instruments for administering medicines being especially those including microneedles and/or microneedle arrangements or structures for use in the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; apparatus and instruments for administering medicines being especially those including microneedles and/or microneedle arrangements for use in the dermal, transdermal, mucosal and transmucosal sampling of body fluids; medical apparatus and instruments for administration of pharmaceuticals and biotechnological molecules using needle-shaped microstructures in the nature of medical , including in the form of plasters to be used on the skin; injection instruments with microneedles for pharmaceuticals; parts of the above goods being especially microneedles and/or microneedle arrangements, for use in the administration of pharmaceuticals and biotechnological molecules

Pharmaceutical research and development services, namely, formulation of medicines being medical plasters with microneedles for use on the skin

Medical consulting of patients and specialist staff, especially physicians, with respect to systems and instruments for administering medicines, especially those including microneedles and/or microneedle arrangements or structures for use in the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; medical services in the nature of formulation and administration of medicines being medical , including through plasters with microneedles for use on the skin

Pharmaceutical products for the transdermal delivery of pharmaceuticals, namely vaccines, anti-viral therapies, immunotherapies, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases and veterinary products for the transdermal delivery of pharmaceuticals, namely vaccines, anti-viral therapies, immunotherapies, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases; medical preparations for the treatment of obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases; medical preparations for immunotherapies; veterinary preparations for the treatment of obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases; veterinary preparations for immunotherapies; medical plasters; all of the above goods not for treating skin diseases; medical dressings

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 12, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 12, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 31, 2025 MAFR
NEW APPLICATION ENTERED
Jul 31, 2025 NWAP